4640 Results

People

  1. Saltz
    Saltz
  2. O'Reilly
    O'Reilly
  3. Abou-Alfa
    Abou-Alfa
  4. Kelsen
    Kelsen
  5. Ilson
    Ilson
  6. Kemeny
    Kemeny
  7. Janjigian
    Janjigian
  8. Reidy
    Reidy
  9. Jarnagin
    Jarnagin
  10. D'Angelica
    D'Angelica

Groups

  1. Gastrointestinal Oncology Service (4640)
  2. Solid Tumor Oncology Division (4640)
  3. Department of Medicine (4638)
  4. Center for Pancreatic Cancer Research (2270)
  5. Surgery (1040)
  6. Survivorship Research (992)
  7. Epidemiology and Biostatistics (828)
  8. GSK Faculty (793)
  9. Department of Pathology and Laboratory Medicine (723)
  10. Biostatistics Service (661)
  1. "Gastrointestinal Oncology Service"
Formats
  1. Journal Article (2302)
  2. Meeting Abstract (1841)
  3. Review (139)
  4. Book Section (123)
  5. Editorial (93)
  6. Guidelines (36)
  7. Correspondence (33)
  8. Conference Paper (23)
  9. Miscellaneous (21)
  10. Research Letter (17)
  11. Book Whole (12)
Groups
  1. Gastrointestinal Oncology Service (4640)
  2. Solid Tumor Oncology Division (4640)
  3. Department of Medicine (4638)
  4. Center for Pancreatic Cancer Research (2270)
  5. Surgery (1040)
  6. Survivorship Research (992)

More Groups

People
  1. Leonard Saltz (790)
  2. Eileen O'Reilly (780)
  3. Ghassan Abou-Alfa (568)
  4. Nancy Kemeny (543)
  5. David Kelsen (537)
  6. David Ilson (433)

More People

Years
  1. 2025 (118)
  2. 2024 (307)
  3. 2023 (362)
  4. 2022 (346)
  5. 2021 (345)
  6. 2020 (326)

More Years

Publications
  1. Journal of Clinical Oncology (1276)
  2. Annals of Oncology (320)
  3. Annals of Surgical Oncology (140)
  4. Cancer (127)
  5. Clinical Cancer Research (107)
  6. Cancer Research (94)

More Publications

Publishers
  1. American Society of Clinical Oncology (1355)
  2. Oxford University Press (447)
  3. Elsevier Inc. (404)
  4. Springer (310)
  5. American Association for Cancer Research (279)
  6. Wiley Blackwell (239)

More Publishers

Results (4640)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Stereotactic body radiation vs. intensity-modulated radiation for unresectable pancreatic cancer
    Meeting Abstract

    Park, J. J.; Hajj, C.; Reyngold, M.; Shi, W.; Zhang, Z.; Cuaron, J. J.; Crane, C. H.; O'Reilly, E. M.; Lowery, M. A.; Yu, K. H.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Necuparanib combined with nab-paclitaxel + gemcitabine in patients with metastatic pancreatic cancer: Phase 2 results
    Meeting Abstract

    O'Reilly, E. M.; Mahalingam, D.; Roach, J. M.; Miller, P. J.; Rosano, M. E.; Krause, S.; Avery, W.; Bekaii-Saab, T. S.; Shao, S. H.; Richards, D. A.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Results of a randomized phase II trial of an anti-notch 2/3, tarextumab (OMP-59R5, TRXT, anti-Notch2/3), in combination with nab-paclitaxel and gemcitabine (Nab-P+Gem) in patients (pts) with untreated metastatic pancreatic cancer (mPC)
    Meeting Abstract

    O'Reilly, E. M.; Sahai, V.; Bendell, J. C.; Bullock, A. J.; LoConte, N. K.; Hatoum, H.; Ritch, P. S.; Hool, H.; Leach, J. W.; Sanchez, J.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Hepatic artery therapies for unresectable colorectal liver metastases: Pooled survival analysis of 968 patients from TACE, yttrium-90, and HAI studies
    Meeting Abstract

    Moutinho, V.; Connell, L. C.; D'Angelica, M. I.; Kemeny, N. E.
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • In vitro functional analysis of HER2 variants in lung cancers to evaluate their oncogenic activity and predict clinical response to HER2 targeted therapies
    Meeting Abstract

    Offin, M.; Olah, Z. T.; Sabari, J. K.; Tandon, N.; Feldman, D.; Abou-Alfa, G. K.; Lok, B. H.; Burck, N.; Tarcic, G.; Miron, B.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • A phase I/II trial of MEK162 in combination with gemcitabine (G) and cisplatin (C) for patients (pts) with untreated advanced biliary cancer (ABC)
    Meeting Abstract

    Lowery, M. A.; O'Reilly, E. M.; Harding, J. J.; Yu, K. H.; Cercek, A.; Hollywood, E.; Salehi, E.; Margona, E.; Bradley, M.; Witter, T.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Phase IB trial of ADI-PEG 20 (A) plus nab-paclitaxel (nab-P) and gemcitabine (gem) in patients with advanced pancreatic cancer (PC)
    Meeting Abstract

    Lowery, M. A.; Harding, J. J.; Yu, K. H.; Kelsen, D. P.; Bomalaski, J. S.; Glassman, D. C.; Covington, C. M.; Brenner, R.; Hollywood, E.; Barba, A.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • ClarIDHy: A phase 3, multicenter, randomized, double-blind study of AG-120 vs placebo in patients with an advanced cholangiocarcinoma with an IDH1 mutation
    Meeting Abstract

    Lowery, M. A.; Abou-Alfa, G. K.; Valle, J. W.; Kelley, R. K.; Goyal, L.; Shroff, R. T.; Javle, M. M.; Borad, M. J.; Cleary, J. M.; El-Khoueiry, A. B.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • A prospective analysis of germline alterations (GA) in biliary tract cancer (BTC)
    Meeting Abstract

    Lowery, M. A.; Jordan, E.; Kemel, Y.; Mukherjee, S.; Cercek, A.; Kemeny, N. E.; Varghese, A. M.; Rusek, M.; Boucher, T. M.; Mandelker, D.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • First-in-class oral ERK1/2 inhibitor Ulixertinib (BVD-523) in patients with advanced solid tumors: Final results of a phase I dose escalation and expansion study
    Meeting Abstract

    Li, B. T.; Janku, F.; Patel, M. R.; Sullivan, R. J.; Flaherty, K.; Buchbinder, E. I.; Lacouture, M. E.; Varghese, A. M.; Wong, D. J. L.; Sznol, M.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save